Strides Pharma Inc. recalls Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101,
Strides Pharma recalls Losartan Potassium Tablets 50mg (Rx Only) due to AZIDO impurity levels above acceptable limits. Affected lots from June 2022 to January 2023.
Recall notice
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Contact the company & request your remedy
What happened, in plain English
Strides Pharma is recalling Losartan Potassium Tablets 50mg (Rx Only) because they contain AZIDO impurities at levels above safety limits. This could pose a health risk if taken as prescribed. Read more at govinfonow.com/recall/34683-strides-pharma-recalls-losartan-50mg-tablets-with-azido-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/34683-strides-pharma-recalls-losartan-50mg-tablets-with-azido-impurity-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0973-2022
Cite this page
“Strides Pharma recalls Losartan 50mg tablets with AZIDO impurity risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/34683-strides-pharma-recalls-losartan-50mg-tablets-with-azido-impurity-risk. Based on FDA recall #D-0973-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0973-2022%22&limit=1).
Why it’s dangerous
The recall is for Losartan Potassium Tablets that contain AZIDO impurities above acceptable limits. This impurity could potentially cause health issues if the medication is taken as directed.
Who’s affected
Prescription drug users who have the specific lots listed in the recall. Patients taking this medication for hypertension or other conditions are most at risk.
How to tell if you have this one
Check the product label for the NDC codes 64380-934-05, 64380-934-08, and the specific lot numbers listed in the recall. The expiration dates range from June 2022 to January 2023.
- Brand
Strides Pharma- Category
Drug
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide- NDC
64380-933-04, 64380-933-05, 64380-933-08, 64380-934-04, 64380-934-05, 64380-934-08, 64380-935-04, 64380-935-05, 64380-935-08
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0972-2022 | Losartan Potassium Tablets, USP 25 mg, Rx only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816. 90 film coated tablets NDC 64380-933-05 1000 film coated tablets NDC 64380-933-08; NDC 64380-933-05 Lot 7901007A, Exp Date Jun-22; Lot 7901144A, 7901178A & 7901179A, Exp Date Sep-22; Lots 7901246A & 7901247A, Exp Date Oct-22; Lot 7901343A, Exp Date Dec-22. NDC 64380-933-08 Lot 7901006A, Exp Date Jun-22; Lot 7901145A & 7901180A, Exp Date Sep-22; Lot 7901181A, Exp Date Oct-22. | 200407 bottles |
| D-0973-2022 | Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816. 90 film coated tablets NDC 64380-934-05 1000 film coated tablets NDC 64380-934-08; NDC 64380-934-05 Lot 7901146A, 7901147A, 7901148A & 7901149A, Exp Date Sep-22; Lot 7901279A, 7901280A, 7901281A, 7901282A, 7901283A & 7901284A, Exp Date Nov-22; Lot 7901359A, 7901360A & 7901361A, Exp Date Dec-22; Lot 7901362A, 7901406A, 7901407A, 7901408A & 7901409A, Exp Date Jan-23. 64380-934-08 Lot 7901008A & 7901009A, Exp Date Jun-22; Lot 7901150A & 7901151A, Exp Date Sep-22; Lot 7901285B, 7901286B, 7901287A, 7901288A, 7901289A, 7901290A, 7901291A, 7901292A, 7901293A & 7901294A, Exp Date Nov-22. | 381456 bottles |
| D-0974-2022 | Losartan Potassium Tablets, USP, 100 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816. 90 film coated tablets NDC 64380-935-05 1000 film coated tablets NDC 64380-935-08; 64380-935-05 Lots 7901047B, 7901048B, 7901049B & 7901050B, Exp Date Jul-22; Lots 7901185A, 7901186A, 7901187A & 7901188A, Exp Date Oct-22; Lots 7901250A, 7901251A & 7901252A, Exp Date Nov-22. 64380-935-08 Lots 7900813B, 7900814B, 7900908A, 7900935A, 7900936A, 7900937A, 7900938A & 7900939B, Exp Date May-22; Lots 7901043A, 7901044A, 7901045A & 7901046A, Exp Date Jul-22; Lots 7901158B, 7901159B, 7901160B, 7901161A, 7901182A & 7901183A, Exp Date Sep-22; Lots 7901184A, 7901189A, 7901190A, 7901191A, 7901192A, 7901193A, 7901194A & 7901195A, Exp Date Oct-22; Lots 7901295B, 7901296B, 7901297B, 7901298B, 7901299B, 7901300B, 7901301B & 7901302B, Exp Date Nov-22; Lots 7901338A, 7901339A, 7901340A, 7901341A & 7901342A, Exp Date Dec-22; Lot 7901387A, Exp Date Jan-23 | 96966 bottles |
What to do — step by step
Check Product Label
Look for the NDC codes 64380-934-05 or 64380-934-08 on the packaging.
Questions people ask
Why is this medication being recalled?
The recall is due to AZIDO impurity levels observed to be above acceptable limits during manufacturing.
What should I do if I have this medication?
The official notice does not specify a remedy, so contact your healthcare provider for guidance.
Which lots are affected?
Affected lots include 7901146A, 7901147A, 7901148A, 7901149A, 7901279A, 7901280A, 7901281A, 7901282A, 7901283A, 7901284A, 7901359A, 7901360A, 7901361A, 7901362A, 7901406A, 7901407A, 7901408A, 7901409A, 7901008A, 7901009A, 7901150A, 7901151A, 7901285B, 7901286B, 7901287A, 7901288A, 7901289A, 7901290A, 7901291A, 7901292A, 7901293A, and 7901294A.
Contact Strides Pharma
We’ve drafted a message you can send Strides Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0973-2022 — Strides Pharma Strides Pharma Hello, I own a Strides Pharma that is covered by recall D-0973-2022 from Strides Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0973-2022 (May 18, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0973-2022 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.